Beam Therapeutics Inc.

BEAMNASDAQHealthcare● Active

$29.92

+$0.52(+1.77%)

Market Cap$3.1B

P/E Ratio—

52W High$36.44

52W Low$15.6

Avg Volume2.0M

Open$29.95

Beta2.20

Employees Ownership Insider Trades

Beam Therapeutics Inc. (BEAM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BEAM · as of Feb 24, 2026

Latest filing snapshot

100,000

+0+0.00%vs prior year

Beam Therapeutics Inc. (BEAM) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

100,000

Change (1Y)

Growth % (1Y)

+0.00%

Revenue / Employee

$1.4K

Net Income / Employee

$-800

Market Cap

$3.1B

BEAM Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-24	2025-12-31	100,000	+0	+0.00%
2025-02-25	2024-12-31	100,000	+0	+0.00%
2024-02-27	2023-12-31	100,000	+40,000	+66.67%
2023-02-28	2022-12-31	60,000	+0	+0.00%
2022-02-28	2021-12-31	60,000	+59,819	+33049.17%
2021-03-15	2020-12-31	181	+63	+53.39%
2020-03-30	2019-12-31	118	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BEAM

Beam Therapeutics Inc.YOU

Agios Pharmaceuticals, Inc.

486$1.7B #5

DNLI

Denali Therapeutics Inc.

443$3.1B #6

COGT

Cogent Biosciences, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BEAM peer comparison

About BEAM employees

BEAM Employees · Headcount

Beam Therapeutics Inc. (BEAM) employee data is sourced from the annual SEC 10-K filing. As of 2025, Beam Therapeutics Inc. had 100,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

Beam Therapeutics Inc. employs 100,000 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1,397, reflecting the company's operational efficiency.

Beam Therapeutics Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Beam Therapeutics Inc.'s revenue per employee of $1,397 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

BEAM Employees · 5 questions

As of the latest SEC 10-K filing (2025), Beam Therapeutics Inc. had 100,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Beam Therapeutics Inc. employee counthow many employees does Beam Therapeutics Inc. haveBEAM total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-24